Champions Oncology Statistics
Total Valuation
CSBR has a market cap or net worth of $84.98 million. The enterprise value is $81.88 million.
Important Dates
The next estimated earnings date is Tuesday, March 10, 2026, after market close.
| Earnings Date | Mar 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CSBR has 13.89 million shares outstanding. The number of shares has increased by 4.06% in one year.
| Current Share Class | 13.89M |
| Shares Outstanding | 13.89M |
| Shares Change (YoY) | +4.06% |
| Shares Change (QoQ) | +4.85% |
| Owned by Insiders (%) | 26.50% |
| Owned by Institutions (%) | 11.34% |
| Float | 5.19M |
Valuation Ratios
The trailing PE ratio is 35.07 and the forward PE ratio is 122.40.
| PE Ratio | 35.07 |
| Forward PE | 122.40 |
| PS Ratio | 1.44 |
| Forward PS | 1.37 |
| PB Ratio | 20.38 |
| P/TBV Ratio | 22.16 |
| P/FCF Ratio | 15.07 |
| P/OCF Ratio | 13.66 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 20.62, with an EV/FCF ratio of 14.52.
| EV / Earnings | 32.87 |
| EV / Sales | 1.40 |
| EV / EBITDA | 20.62 |
| EV / EBIT | 33.24 |
| EV / FCF | 14.52 |
Financial Position
The company has a current ratio of 0.96, with a Debt / Equity ratio of 1.28.
| Current Ratio | 0.96 |
| Quick Ratio | 0.91 |
| Debt / Equity | 1.28 |
| Debt / EBITDA | 0.94 |
| Debt / FCF | 0.96 |
| Interest Coverage | 91.22 |
Financial Efficiency
Return on equity (ROE) is 98.94% and return on invested capital (ROIC) is 1,811.03%.
| Return on Equity (ROE) | 98.94% |
| Return on Assets (ROA) | 5.56% |
| Return on Invested Capital (ROIC) | 1,811.03% |
| Return on Capital Employed (ROCE) | 30.71% |
| Weighted Average Cost of Capital (WACC) | 5.85% |
| Revenue Per Employee | $274,291 |
| Profits Per Employee | $11,695 |
| Employee Count | 213 |
| Asset Turnover | 2.11 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -73,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -44.36% in the last 52 weeks. The beta is 0.35, so CSBR's price volatility has been lower than the market average.
| Beta (5Y) | 0.35 |
| 52-Week Price Change | -44.36% |
| 50-Day Moving Average | 6.77 |
| 200-Day Moving Average | 6.83 |
| Relative Strength Index (RSI) | 35.52 |
| Average Volume (20 Days) | 6,203 |
Short Selling Information
The latest short interest is 79,929, so 0.58% of the outstanding shares have been sold short.
| Short Interest | 79,929 |
| Short Previous Month | 77,421 |
| Short % of Shares Out | 0.58% |
| Short % of Float | 1.54% |
| Short Ratio (days to cover) | 3.90 |
Income Statement
In the last 12 months, CSBR had revenue of $58.42 million and earned $2.49 million in profits. Earnings per share was $0.17.
| Revenue | 58.42M |
| Gross Profit | 29.28M |
| Operating Income | 2.46M |
| Pretax Income | 2.36M |
| Net Income | 2.49M |
| EBITDA | 3.97M |
| EBIT | 2.46M |
| Earnings Per Share (EPS) | $0.17 |
Full Income StatementBalance Sheet
The company has $8.52 million in cash and $5.41 million in debt, with a net cash position of $3.10 million or $0.22 per share.
| Cash & Cash Equivalents | 8.52M |
| Total Debt | 5.41M |
| Net Cash | 3.10M |
| Net Cash Per Share | $0.22 |
| Equity (Book Value) | 4.23M |
| Book Value Per Share | 0.30 |
| Working Capital | -809,000 |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $6.22 million and capital expenditures -$583,000, giving a free cash flow of $5.64 million.
| Operating Cash Flow | 6.22M |
| Capital Expenditures | -583,000 |
| Free Cash Flow | 5.64M |
| FCF Per Share | $0.41 |
Full Cash Flow StatementMargins
Gross margin is 50.11%, with operating and profit margins of 4.22% and 4.26%.
| Gross Margin | 50.11% |
| Operating Margin | 4.22% |
| Pretax Margin | 4.03% |
| Profit Margin | 4.26% |
| EBITDA Margin | 6.80% |
| EBIT Margin | 4.22% |
| FCF Margin | 9.65% |
Dividends & Yields
CSBR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.06% |
| Shareholder Yield | -4.06% |
| Earnings Yield | 2.93% |
| FCF Yield | 6.64% |
Analyst Forecast
The average price target for CSBR is $12.00, which is 96.08% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.00 |
| Price Target Difference | 96.08% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 18.59% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on August 12, 2015. It was a reverse split with a ratio of 1:12.
| Last Split Date | Aug 12, 2015 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
CSBR has an Altman Z-Score of 0.83 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.83 |
| Piotroski F-Score | 7 |
